Form 4: BioAffinity Technologies Director Acquires Shares Through Stock Grant

Robert A. Anderson, a director at bioAffinity Technologies, acquired 8,296 shares of common stock through a grant that vested immediately.

Summary

• On June 12, 2024, Robert A. Anderson, a director of bioAffinity Technologies, Inc. (BIAF), acquired 8,296 shares of common stock.
• The acquisition was a grant of restricted shares that vested immediately.
• The price per share was $0.00.
• Following the transaction, Anderson directly owns 130,152 shares of bioAffinity Technologies, Inc.

Sentiment

Score: 5

Explanation: The document is a neutral disclosure of an insider transaction. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.

Positives

• A director increasing their stake in the company could be seen as a positive signal.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The transaction may have a minor impact on shareholders by slightly diluting the ownership base.

Key Dates

Keywords

bioAffinity Technologies, BIAF, Robert A. Anderson, Director, Stock Grant, Beneficial Ownership, SEC Form 4, Restricted Shares